Viktor Berge
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Prostate Cancer Diagnosis and Treatment 35
- Prostate Cancer Treatment and Research 14
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Alicia Llorente (5 shared papers)Kirsten Sandvig (4 shared papers)Tore Skotland (3 shared papers)Therese Seierstad (2 shared papers)Aud Svindland (11 shared papers)Helena Simolin (1 shared paper)Dimple Kauhanen (1 shared paper)Kim Ekroos (1 shared paper)
- Journals
- European Urology (5 papers)The Journal of Urology (5 papers)Apmis (4 papers)British Journal of Urology (3 papers)Oncotarget (3 papers)
- Partner nations
- NorwayUnited KingdomGermany
In The Last Decade
Viktor Berge
62 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 79
- Pulmonary and Respiratory Medicine 931
- Cancer Research 244
- Molecular Biology 997
- Urology 49
- Oncology 94
Countries citing papers authored by Viktor Berge
This map shows the geographic impact of Viktor Berge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viktor Berge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viktor Berge more than expected).
Fields of papers citing papers by Viktor Berge
This network shows the impact of papers produced by Viktor Berge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viktor Berge. The network helps show where Viktor Berge may publish in the future.
Co-authors
The 25 scholars most cited alongside Viktor Berge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 305 | |
| 2 | 2013 | 253 | |
| 3 | 2017 | 218 | |
| 4 | 2015 | 200 | |
| 5 | 2014 | 189 | |
| 6 | 2014 | 100 | |
| 7 | 2017 | 90 | |
| 8 | 2016 | 84 | |
| 9 | 2017 | 60 | |
| 10 | 2011 | 57 | |
| 11 | 2014 | 53 | |
| 12 | 2015 | 52 | |
| 13 | 2016 | 49 | |
| 14 | 2013 | 48 | |
| 15 | 2010 | 38 | |
| 16 | 2013 | 37 | |
| 17 | 2017 | 37 | |
| 18 | 2016 | 33 | |
| 19 | 2006 | 30 | |
| 20 | 2019 | 27 |
About Viktor Berge
Viktor Berge is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Immunology, Urology and Biomedical Engineering, having authored 64 papers that have together received 2.3k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (14 papers), Ultrasound and Hyperthermia Applications (7 papers), Complement system in diseases (6 papers), Extracellular vesicles in disease (5 papers), Urinary Bladder and Prostate Research (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (931 citations), Cancer Research (244 citations), Molecular Biology (997 citations), Urology (49 citations) and Oncology (94 citations). Viktor Berge has collaborated with scholars based in Norway, United Kingdom and Germany. Frequent co-authors include Alicia Llorente, Kirsten Sandvig, Tore Skotland, Therese Seierstad, Aud Svindland, Helena Simolin, Dimple Kauhanen, Kim Ekroos, Eduard Baco and Lars Magne Eri. Their work appears in journals such as European Urology, The Journal of Urology, Apmis, British Journal of Urology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.